1.Clinical Observation of Electroacupuncture at Bilateral Auditory Fainting Region plus Body Acupuncture for Tinnitus
Shanghai Journal of Acupuncture and Moxibustion 2015;(12):1198-1199
ObjectiveTo observe the clinical efficacy of electroacupuncture at bilateral Auditory Fainting Region plus body acupuncture in treating tinnitus.MethodForty patients were randomized into a treatment group and a control group, 20 cases in each group. The treatment group was intervened by electroacupuncture at bilateral Auditory Fainting Region in addition to the routine acupuncture, once each day, 7 times as a course, with 1-day interval between two courses; the control group was by routine acupuncture by selecting Ermen (TE21), Tinggong (SI19), Tinghui (GB2), Yifeng (TE17), Zhongzhu (TE3), and Xiaxi (GB43) on the affected side, once a day, 7 times as a course, with 1-day interval between two courses. The therapeutic efficacies were observed and compared after 4 treatment courses.ResultThe total effective rate was 85% in the treatment group, versus 60% in the control group, and the difference was statistically significant (P<0.05).ConclusionElectroacupuncture at bilateral Auditory Fainting Region plus body acupuncture can produce a more significant therapeutic efficacy.
2.Exercise Prescription of Lumbar Spinal Stenosis
Xinhua MIAO ; Cuilan WANG ; Yunzhu LAI ; Pande ZHANG ; Xiurong GAO ; Guodian WANG
Chinese Journal of Rehabilitation Theory and Practice 1998;4(4):150-152
Objective: To study the effects of mm. abdominis exercise on lumbar spinal stenosis. Methods: 9 patients with lumbar spinal stenosis were treated with mm. abdominis exercises. The static and dynamic strength indexes, the sagittal diameter of canales spinalis tested by ultrasonography were observed and compared before and after treatment. Results: The effect of 3 patients was excellent, 5 good and 1 bad, and the strengths of mm. abdominis increased after treatment. The sagittal diameter of canales spinalis were 8.72±0.44mm and 10.78±0.44mm respectively before and after treatment. The difference was significant (P<0.001). Conclusion: It is suggested that mm. abdominis exercise is an effective technique in management of lumgar spinal stenosis.
3.Risk factors for postoperative delirium in frail elderly patients undergoing cardiac surgery and development of a prediction model
Yunzhu LU ; Songqing GUO ; Xin CHEN ; Ju GAO
Chinese Journal of Anesthesiology 2022;42(11):1316-1319
Objective:To identify the risk factors for postoperative delirium (POD) in frail elderly patients undergoing cardiac surgery and develop a ROC prediction model.Methods:The medical records of patients of either sex, aged ≥65 yr, of American Society of Anesthesiologists Physical Status classification Ⅲ or Ⅳ, with frailty index score>0.25, underwent open heart surgery under cardiopulmonary bypass (CPB) from January 2022 to June 2022, were collected retrospectively.The patients were divided into POD group and non-POD group according to POD occurred within 7 days after operation.Clinical information such as gender, age, Mini-mental State Examination score, past medical history, results of the laboratory test before surgery, operation time, cerebral oxygen saturation (rSO 2), rSO 2 baseline (rSO 2 baseline), lowest intraoperative rSO 2 value before, during and after CPB (CPB 1rSO 2 lowest, CPB 2rSO 2 lowest, CPB 3rSO 2 lowest) , the greatest decrease in intraoperative rSO 2 from the baseline value before, during and after CPB (CPB 1rSO 2 decrease, CPB 2rSO 2 decrease, CPB 3rSO 2 decrease) were recorded.Multivariate logistic regression analysis was used to identify the risk factors for POD, and the receiver operating characteristic (ROC) curve was drawn to evaluate the accuracy of the related risk factors. Results:A total of 130 patients were enrolled, with 32 cases in POD group and 98 cases in non-POD group, and the incidence of POD was 24.6%.The results of logistic regression analysis showed that the CPB 2rSO 2 decrease, CPB 2rSO 2 lowest and operation time were independent risk factors for POD ( P<0.05). The area under the ROC curve (95% confidence interval) of CPB 2rSO 2 decrease>11.2% predicting POD was 0.655 (0.533-0.778), sensitivity 68.9%, and specificity 62.9%.The area under the ROC curve (95% confidence interval) of operation time>237.5 min predicting POD was 0.751 (0.652-0.849), sensitivity 62.5%, and specificity 78.6%. Conclusions:CPB 2rSO 2 decrease, CPB 2rSO 2 lowest and operation time are independent risk factors for POD in frail elderly patients undergoing cardiac surgery; both CPB 2rSO 2 decrease and operation time can effectively predict the occurrence of POD in frail elderly patients undergoing cardiac surgery.
4.Recommendations for prescription review of antipyretic-analgesics in symptomatic treatment of children with fever
Xiaohui LIU ; Xing JI ; Lihua HU ; Yuntao JIA ; Huajun SUN ; Qinghong LU ; Shengnan ZHANG ; Ruiling ZHAO ; Shunguo ZHANG ; Yanyan SUN ; Meixing YAN ; Lina HAO ; Heping CAI ; Jing XU ; Zengyan ZHU ; Hua XU ; Jing MIAO ; Xiaotong LU ; Zebin CHEN ; Hua CHENG ; Yunzhu LIN ; Ruijie CHEN ; Xin ZHAO ; Zhenguo LIU ; Junli ZHANG ; Yuwu JIANG ; Chaomin WAN ; Gen LU ; Hengmiao GAO ; Ju YIN ; Kunling SHEN ; Baoping XU ; Xiaoling WANG
Chinese Journal of Applied Clinical Pediatrics 2022;37(9):653-659
Antipyretic-analgesics are currently one of the most prescribed drugs in children.The clinical application of antipyretic-analgesics for children in our country still have irrational phenomenon, which affects the therapeutic effect and even poses hidden dangers to the safety of children.In this paper, suggestions were put forward from the indications, dosage form/route, dosage suitability, pathophysiological characteristics of children with individual differences and drug interactions in the symptomatic treatment of febrile children, so as to provide reference for the general pharmacists when conducting prescription review.
5.Evidenced-based Evaluation of Personnel Training Mode in Pharmacy Intravenous Admixture Services in China
Chunsong YANG ; Lingli ZHANG ; Yunzhu LIN ; Lu HAN ; Yeli WANG ; Shan GAO ; Wenrong JIN
China Pharmacy 2019;30(5):708-711
OBJECTIVE: To systematically evaluate the mode of personnel training in pharmacy intravenous admixture services (PIVAS) in China, and to provide reference for the comprehensive training of pharmacist in PIVAS in China. METHODS: PubMed, Embase, Cochrane Library, CBM, CJFD, VIP and Wanfang database were searched from the establishment of database to Sept. 2018. Studies which evaluated the training mode of PIVAS in China were included, and the results were presented by descriptive analysis in respects of training objects, training objectives, contents and evaluation indicators. RESULTS: A total of 5 literatures were included. The research types were 2 before-after control studies, 2 experience sharing studies and 1 review. 3 subjects were pharmacists, 1 subject was clinical pharmacists, and 1 subject was nurses. The training objectives were comprehensive quality training, clinical rational drug use level, pharmacy personnel training path and professional service ability. The specific training content of the training mode varied greatly, including professional theoretical knowledge, practical operation ability, pre-job training, professional psychological quality, professional ethics and laws and regulations, continuing education learning ability, career development planning and teaching ability. There were great differences in the evaluation indicators of training effectiveness, which were mainly reflected in team execution motivation and creativity, discoveny rate of unreasonable doctor’s advice, work efficiency, service quality, drug treatment level and satisfaction of PIVAS, etc. CONCLUSIONS: There are certain differences in the training objectives, training targets, specific contents and evaluation indicators of the PIVAS pharmacist training model in China. It is necessary to use the evidence- based method to construct the training mode for PIVAS pharmacist to provide support for clinical intravenous drug use.
6.Systematic Evaluation of Current Status of Charges in PIVAS of China
Chunsong YANG ; Tianyi ZHANG ; Lingli ZHANG ; Yunzhu LIN ; Lu HAN ; Yeli WANG ; Shan GAO ; Wenrong JING
China Pharmacy 2019;30(17):2414-2418
OBJECTIVE: To systematically evaluate current status of charges in pharmacy intravenous admixture services (PIVAS), and to provide reference for the formulation of China’s pharmacy intravenous admixture services (PIVAS) charging standards. METHODS: Retrieved from PubMed, Embase, Cochrane library, CBM, CNKI, VIP, Wanfang database and related goverment websets, the literatures about current status evaluation of charges in PIVAS of China were collected during the establishment of database to Jan. 2019. Cost estimation, charge standard, influential factors and other indicators were collected, and the results were presented by descriptive analysis. RESULTS: A total of 5 literatures were included, all of which were reviewed. According to the existing literatures, except for Shandong, Guangdong and Yunnan provinces, there were no regional charge standards in other provinces (districts and cities). The cost estimation methods of PIVAS in these three provinces were basically the same. The cost could be obtained by adding up the business fees, labor fees, fees of medical instruments purchase and use, indirect fees etc. Dispensing charges in PIVAS were 3-5 yuan per piece for general drug, 5 yuan per piece for antibiotics and 8-12 yuan per piece for cancer chemotherapeutics, 20-35 yuan per piece for TPN. The charging level was mainly affected by local prices, PIVAS scale, hardware investment, management and other factors. CONCLUSIONS: There is no unified charging standard for PIVAS in most provinces (districts, cities) of China. The cost estimation methods of the hospitals from the included literatures are basically the same. It is necessary to construct national PIVAS charging standard and cost estimation method, which could provide a basis for formulating the price of medical and health services.
7.Status Quo of Cost Estimation and Systematic Review in Pharmacy Intravenous Admixture Services in China
Chunsong YANG ; Tianyi ZHANG ; Lingli ZHANG ; Yunzhu LIN ; Lu HAN ; Yeli WANG ; Shan GAO ; Wenrong JIN
China Pharmacy 2019;30(19):2707-2711
OBJECTIVE: To systematically evaluate the status quo of cost estimation in pharmacy intravenous admixture services (PIVAS), and to provide cost basis for the construction of PIVAS in China. METHODS: Retrieved from PubMed, Embase, Cochrane library, CBM, CNKI, CSJD and Wanfang database from database establishment to Jan. 2019, the studies about the status quo of cost estimation in PIVAS of China were included. The descriptive analysis was conducted for content and method of cost estimation, infection to hospital. RESULTS: A total of 17 literatures were included, involving 8 before and after control studies, 6 experience sharing studies and 3 reviews. Existing reports showed that the estimation contents and methods of PIVAS cost were roughly the same. The cost included manpower, medical and health materials, fixed asset purchase, depreciation, repair costs, medicine cost and indirect costs. At the same time, the infection to hospital were reported, such as in manpower adopting, formulating detailed management measures and systems, concurrent allocation of the same kind of drugs, shortening infusion preparation and replacement time, in order to save manpower cost. CONCLUSIONS: PIVAS cost calculation method is roughly the same in some hospitals, but there is no uniform standard. It is necessary to further improve the PIVAS cost measurement standard and provide a basis for the construction and development of PIVAS in China.
8.Immunostimulatory gene therapy combined with checkpoint blockade reshapes tumor microenvironment and enhances ovarian cancer immunotherapy.
Yunzhu LIN ; Xiang WANG ; Shi HE ; Zhongxin DUAN ; Yunchu ZHANG ; Xiaodong SUN ; Yuzhu HU ; Yuanyuan ZHANG ; Zhiyong QIAN ; Xiang GAO ; Zhirong ZHANG
Acta Pharmaceutica Sinica B 2024;14(2):854-868
Immune evasion has made ovarian cancer notorious for its refractory features, making the development of immunotherapy highly appealing to ovarian cancer treatment. The immune-stimulating cytokine IL-12 exhibits excellent antitumor activities. However, IL-12 can induce IFN-γ release and subsequently upregulate PDL-1 expression on tumor cells. Therefore, the tumor-targeting folate-modified delivery system F-DPC is constructed for concurrent delivery of IL-12 encoding gene and small molecular PDL-1 inhibitor (iPDL-1) to reduce immune escape and boost anti-tumor immunity. The physicochemical characteristics, gene transfection efficiency of the F-DPC nanoparticles in ovarian cancer cells are analyzed. The immune-modulation effects of combination therapy on different immune cells are also studied. Results show that compared with non-folate-modified vector, folate-modified F-DPC can improve the targeting of ovarian cancer and enhance the transfection efficiency of pIL-12. The underlying anti-tumor mechanisms include the regulation of T cells proliferation and activation, NK activation, macrophage polarization and DC maturation. The F-DPC/pIL-12/iPDL-1 complexes have shown outstanding antitumor effects and low toxicity in peritoneal model of ovarian cancer in mice. Taken together, our work provides new insights into ovarian cancer immunotherapy. Novel F-DPC/pIL-12/iPDL-1 complexes are revealed to exert prominent anti-tumor effect by modulating tumor immune microenvironment and preventing immune escape and might be a promising treatment option for ovarian cancer treatment.